Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9801 USD | -16.23% | -35.52% | -27.40% |
Apr. 18 | Top Premarket Decliners | MT |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 14.84M | Sales 2025 * | 28.61M | Capitalization | 2.69M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | - | EV / Sales 2024 * | 0.18 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.09 x |
P/E ratio 2024 * |
-3.38
x | P/E ratio 2025 * |
-98
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.16% |
Latest transcript on INVO Bioscience, Inc.
1 day | -16.23% | ||
1 week | -35.52% | ||
Current month | -13.27% | ||
1 month | -14.03% | ||
3 months | -7.54% | ||
6 months | -39.50% | ||
Current year | -27.40% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 17-10-10 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 21-06-13 |
J. Chris Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 19-12-15 |
Barbara Ryan
BRD | Director/Board Member | 64 | 20-09-13 |
Corporate Secretary | 55 | 08-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.9801 | -16.23% | 605,301 |
24-04-24 | 1.17 | -10.00% | 457,087 |
24-04-23 | 1.3 | +4.84% | 610,741 |
24-04-22 | 1.24 | -9.49% | 917,858 |
24-04-19 | 1.37 | -9.87% | 1,395,750 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.40% | 3.21M | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+3.21% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+12.38% | 25.66B |
- Stock Market
- Equities
- INVO Stock